The development of colorectal cancer involves a multistage process in which a number of oncogenes and tumour suppressor genes are known to play a role (for review see Fearon & Jones, 1992) . The APC gene which is located on chromosome 5 region 5q21 (Kinzler et al., 1991) is known to be involved in the sequence of events leading to colorectal tumour development. A second gene called MCC (Mutated in Colorectal Cancer) also maps to this chromosome region (Kinzler et al., 1991) . Deletions involving 5q have been shown to occur in about 40% of colorectal tumours (AshtonRickardt et al., 1989; Laurent-Puig et al., 1992) .
Allele loss (Ponder, 1988) has been detected in tumours by the use of Restriction Fragment Length Polymorphisms (RFLP's) and more recently by the use of microsatellites. Radioactive RFLP analysis of allele loss has many drawbacks such as the length of time to produce results, expense of restriction enzymes and isotopes, possible ambiguity of results, safety aspects associated with isotope use, artefacts due to incomplete digestion, and a high level of uninformative (homozygous) cases. Microsatellites are short tandem repeat sequences which exhibit length polymorphisms (Edwards et al., 1991; Weber et al., 1989) . They occur throughout the genome and are highly informative. Sequences based on (dC-dA)n dinucleotide repeats have been described that are located at, or linked to, several important gene loci, and among these are two CA repeat stretches linked to the APC gene which we have used in this study. Sequences containing CA repeat regions can be specifically amplified using a radioactive PCR method, which allows the products to be detected by autoradiography of polyacrylamide gels. This method has yielded results for allele loss (Futreal et al., 1992; Jones & Nakamura 1992; Louis et al., 1992) . Jones & Nakamura (1992) and Louis et al. (1992) obtained the same allele loss results using RFLP's and CA repeats, indicating that CA repeats are a valid alternative to RFLP's for allele loss studies. However an intrinsic problem with dinucleotide repeats is the production of 'stutter' bands which are thought to be caused by the Taq polymerase in the PCR failing to read through the repeat region thereby generating smaller fragments (Litt, 1991 The primer sequences used were as described by for the CA repeat proximal to APC located at the D5S82 locus, and as described by van Leeuwen et al. (1991) Before beginning the study we assigned a ratio of less than or equal to 0.50 to be indicative of loss on the basis that tumours containing no normal contaminating cells and showing complete allele loss would theoretically give a ratio of 0.00, but because some tumours in the series contained an estimated 50% normal cells then complete allele loss in these tumours would give an allele ratio of only 0.50.
Results
The proportion of samples which were informative (i.e. heterozygous) with the D5S299 primers was 77% and for the D5S82 primers this value was 69%. We found 50% of the samples were informative with both sets of primers and only one sample out of 26 was not informative with either primer set. Thus information about allele loss was obtained in 96% of cases. Non informative samples are easily determined, as only one fluorescent peak is seen for those samples ( Figure  1) .
The PCR product size range observed was 158-192 and 173-181 base pairs for the D5S299 and D5S82 primer pairs respectively as sized by the GS2500P size standard. Samples with allele size differences of as little as two base pairs could easily be resolved using the Genescan software.
A sample with a normal allele ratio, approaching 1.0, as calculated from peak areas is shown in Figure 2 . The relative heights of the two alleles are similar in both the normal and tumour sample. This can be compared with Figure 3a where a sample with definite visual allele loss, with a ratio of 0.28, is shown. The Genescan software enables the fluorescent peaks from a patients normal and tumour DNA (two separate gel lanes) to be overlaid, by changing the printout colour for one of the lanes. This enhances the visual effect of allele loss, as seen from Figure 3b Allele ratio (Ti :T2/N1: N2) Figure 4 Bar graph showing the range of allele ratios produced from both the D5S82 and D5S299 primers in this series. Allele ratios given are the means of four repeat assays. Results are shown for all informative cases (13 samples were informative with both primers). The cut off value for allele loss is 0.50 (see text for explanation of allele ratios).
of each sample ( Table I ). The samples which were informative with both sets of primers gave similar allele ratio results with each primer set (Table II) . We did not find gel to gel, and PCR to PCR variation to be a problem as repeated assays gave consistent results and at least four repeats were carried out for each sample to ensure that our results were accurate and consistent, and to give a mean value for the allele ratio. Using this method we have detected loss in the APC/MCC region in ten out of 25 (40%) informative samples, using a cut off value of 0.50. The range of allele ratios for the 25 Results for all informative samples with the D5S82 primers are shown. The proportion of cancer cells in the tumour was estimated by H&E staining. The results for allele loss were consistent (Table I ) and the ratios appear to form a bimodal distribution (Figure 4) where tumours with no allele loss are separated from the tumours which do show loss. However, a larger number of samples needs to be assayed before this distribution can be determined to be a significant result. The cut-off value for loss of 0.50 appears to be consistent with the bimodal distribution, but there are borderline samples in the 0.50-0.59 range which may possibly also have allele loss. Further studies may indicate that the cut-off value for allele loss could be increased to 0.59 on the basis of the bimodal distribution.
We found that the use of fluorescent technology to detect and analyse CA repeat sequences has made it much easier to identify and quantitate allele bands among non specific stutter bands. The method described here is much more rapid than RFLP analysis or radioactive detection of CA repeats and the results are quantitated automatically. The throughput is rapid as the DNA sequencer used can analyse 24 or 36 lanes simultaneously, and the use of an internal size standard in each lane means that lane to lane variation does not affect sizing of the PCR products. The fluorescent detection method is so sensitive that only 1 sLI of the PCR product needs to be run on the gel therefore the cost of PCR reagents used can be reduced by the reduction in total PCR volumes. CA repeats are more informative than RFLPs and the use of fluorescence as a detection method has obviated the need for radioisotopes.
PCR as a technique is much more sensitive than Southern blotting and requires much less DNA. Thus, DNA extracted from minute amounts of tissue specimens can be assayed by PCR. The added sensitivity of the fluorescent PCR technique means that even less template DNA is required for successful amplification. The fluorescent PCR technique is more rapid since the enhanced sensitivity of detection requires significantly fewer PCR cycles to achieve a detectable result.
Due to the speed of our technique (24 samples from DNA stock to an allele loss result in 8 h) all specimens can be assayed in four or more separate PCR reactions very quickly to ensure that the results are reproducible. Furthermore, since the Genescan analysis system allows four different dye colours to be assayed simultaneously, multiplex fluorescent PCR's are possible enabling more than one locus to be analysed at the same time in one PCR tube (L.C. unpublished results). If multiplex PCR is not possible for all primer combinations then multiple separate fluorescent PCR reaction products can be loaded into a single lane for electrophoresis. For both multiplex PCR and multiple loading the loci under test have to be separated either by the fluorescent label or the size range of the products.
The technique also works well using DNA extracted from formalin fixed, paraffin embedded material (results not shown). This is an important factor since paraffin embedded material is more common in historical series where follow up data is known. In our hands the technique works well on DNA prepared by the method described by Bell et al. (1991) . The PCR protocol is as in Materials and methods but more PCR cycles are performed (typically 25-30).
In summary, the advantages of this allele loss detection technique are quantitation of allele loss; accurate sizing of PCR products; rapid generation of results as compared to RFLP/radioactive CA repeat analyses; high sample throughput; the possibility of assaying several markers simultaneously by multiplex PCR or multiple loading; the requirement for very little DNA (from fresh or paraffin embedded tissue); and the non-radioactive nature of the assay. Thus results on allele loss can be produced rapidly, for several loci simultaneously, for many samples. The speed and reproducibility of this technique could enable it to be used as a diagnostic or prognostic test in neoplasia. This is the first description of detection of allele loss in the APC/MCC region determined by the use of fluorescent CA repeats. Our finding of loss in this region in 40% of colorectal samples is comparable to figures given by AshtonRickardt et al. (1989) and Laurent-Puig et al. (1992) using RFLP probe techniques for 5q21-22. Any microsatellites which are found to map within the APC gene itself would make our assay more specific for APC loss, as small deletions may be missed, thus underestimating the frequency of loss, with the primers used in this study to validate the technique of allele loss detection.
A larger series of colorectal cancer samples analysed in this way, accompanied by patient survival data, will enable us to determine whether deletions in the APC/MCC region, and also in other regions of the genome, are important for patient prognosis and this is now underway. As the range of VNTR's and microsatellites identified that are linked to important cancer genes increases, the development of a single multiplexed molecular test for loss of heterozygosity in common cancers will become a distinct possibility.
